{"transactions":[{"id":697223,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-04T21:04:31.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":32246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2026, the reporting person was granted 32,246 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 32,246 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 32,246 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."}],"balance_after":32246,"derivative":{"underlying":"Common Stock","underlying_shares":32246},"source":{"system":"sec-edgar","filing":"0001437749-26-025715","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926025715/rdgdoc.xml","form_type":"4"}},{"id":1931789,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T00:00:18.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1,"expiration_date":"2033-03-30","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-022423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123022423/doc4.xml","form_type":"4"}},{"id":1953512,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-14T22:00:26.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 11, 2021, the reporting person was granted an award of 13,333 RSUs, 50% of which vested on March 11, 2022, with the remaining 50% having vested on March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 11, 2021, the reporting person was granted an award of 13,333 RSUs, 50% of which vested on March 11, 2022, with the remaining 50% having vested on March 11, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001209191-23-018585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123018585/doc4.xml","form_type":"4"}},{"id":1953511,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-14T22:00:26.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":2883,"price":0.96,"value":2767.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs."}],"balance_after":8135,"source":{"system":"sec-edgar","filing":"0001209191-23-018585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123018585/doc4.xml","form_type":"4"}},{"id":1953510,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-14T22:00:26.000Z","date":"2023-03-11","kind":"grant","acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split."}],"balance_after":11018,"source":{"system":"sec-edgar","filing":"0001209191-23-018585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919123018585/doc4.xml","form_type":"4"}},{"id":2332669,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-15T23:12:11.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":63340,"price":0.31,"value":19635.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the ordinary shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of restricted share units.  This amendment is being filed to address an error in reporting the number of ordinary shares sold pursuant to such election and the sale price per share. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted share units converted into ordinary shares on a one-for-one basis upon vesting of the restricted share units.  This amendment is being filed to address an error in reporting the number of ordinary shares sold pursuant to such election and the sale price per share. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":65292,"source":{"system":"sec-edgar","filing":"0001209191-22-018976","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122018976/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-15"}},{"id":2332667,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2022-03-15T21:01:09.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 11, 2021, the reporting person was granted an award of 200,000 RSUs, 50% of which vested on March 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 11, 2021, the reporting person was granted an award of 200,000 RSUs, 50% of which vested on March 11, 2022."}],"balance_after":100000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-018864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122018864/doc4.xml","form_type":"4"}},{"id":2332666,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-15T21:01:09.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":47132,"price":0.38,"value":17910.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":81500,"source":{"system":"sec-edgar","filing":"0001209191-22-018864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122018864/doc4.xml","form_type":"4"}},{"id":2332665,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-15T21:01:09.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":128632,"source":{"system":"sec-edgar","filing":"0001209191-22-018864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919122018864/doc4.xml","form_type":"4"}},{"id":2654381,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T20:05:10.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":1936000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 23, 2021 and the remaining 75% will vest in equal monthly installments thereafter until June 23, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date."}],"balance_after":1936000,"derivative":{"exercise_price":2.01,"expiration_date":"2031-06-22","underlying":"Ordinary Shares","underlying_shares":1936000},"source":{"system":"sec-edgar","filing":"0000899243-21-025951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000089924321025951/doc4.xml","form_type":"4"}},{"id":2788659,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-15T20:30:21.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer on the relevant vesting date and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, the RSUs shall vest 50% on March 11, 2022 and 50% on March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer on the relevant vesting date and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, the RSUs shall vest 50% on March 11, 2022 and 50% on March 11, 2023."}],"balance_after":200000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-21-011584","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000089924321011584/doc4.xml","form_type":"4"}},{"id":2893129,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-28T00:32:02.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":33868,"price":1.73,"value":58591.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the PSUs. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":28632,"source":{"system":"sec-edgar","filing":"0000899243-21-003518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000089924321003518/doc4.xml","form_type":"4"}},{"id":2893128,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-28T00:32:02.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 62,500 ordinary shares received upon vesting of performance-based stock units (\"PSUs\") on January 25, 2021, which PSUs were subject to performance conditions that have been satisfied. PSUs convert into ordinary shares on a one-for-one basis."}],"balance_after":62500,"source":{"system":"sec-edgar","filing":"0000899243-21-003518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000089924321003518/doc4.xml","form_type":"4"}},{"id":3015357,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-10-03T01:00:18.000Z","date":"2020-09-30","kind":"sale","acquired":false,"shares":56130,"price":1.64,"value":92053.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-027008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000089924320027008/doc4.xml","form_type":"4"}},{"id":3648903,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T16:29:16.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 15, 2019 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":30000,"derivative":{"exercise_price":5.8,"expiration_date":"2029-02-14","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-19-003970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000089924319003970/doc4.xml","form_type":"4"}},{"id":3913656,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B-2 Preferred Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":2466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2466},"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3913655,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B-1 Preferred Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":3038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3038},"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3913654,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A Preferred Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":10980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10980},"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3913653,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":4000,"price":13,"value":52000.0,"ownership":{"direct":true},"balance_after":56130,"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3913652,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":2466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."}],"balance_after":52130,"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3913651,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":3038,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."}],"balance_after":49664,"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3913650,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:12:30.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":10980,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."}],"balance_after":46626,"source":{"system":"sec-edgar","filing":"0001209191-18-034193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/doc4.xml","form_type":"4"}},{"id":3914987,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":26654,"kind":"person","name":"Matthews Judith M.","position":1,"cik":"0001734033","reported_name":"Matthews Judith M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-29T21:13:17.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":23870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 24, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":23870,"derivative":{"exercise_price":13,"expiration_date":"2028-05-23","underlying":"Ordinary Shares","underlying_shares":23870},"source":{"system":"sec-edgar","filing":"0001209191-18-033895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659323/000120919118033895/doc4.xml","form_type":"4"}}]}